Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMRN |
---|---|---|
09:32 ET | 185512 | 83.97 |
09:34 ET | 36765 | 83.91 |
09:36 ET | 82061 | 83.4 |
09:38 ET | 71786 | 83.27 |
09:39 ET | 18479 | 83.62 |
09:41 ET | 47154 | 84.005 |
09:43 ET | 57031 | 83.905 |
09:45 ET | 25126 | 84.245 |
09:48 ET | 30346 | 84.51 |
09:50 ET | 17477 | 84.55 |
09:52 ET | 50939 | 84.925 |
09:54 ET | 73112 | 85.27 |
09:56 ET | 30197 | 85.01 |
09:57 ET | 41943 | 84.78 |
09:59 ET | 23031 | 84.47 |
10:01 ET | 25652 | 84.33 |
10:03 ET | 40185 | 83.84 |
10:06 ET | 17006 | 83.88 |
10:08 ET | 18981 | 83.6 |
10:10 ET | 17694 | 83.49 |
10:12 ET | 17609 | 83.49 |
10:14 ET | 12167 | 83.515 |
10:15 ET | 33660 | 83.61 |
10:17 ET | 58309 | 84.015 |
10:19 ET | 36808 | 83.925 |
10:21 ET | 17885 | 83.43 |
10:24 ET | 12554 | 83.415 |
10:26 ET | 20623 | 83.48 |
10:28 ET | 13149 | 83.39 |
10:30 ET | 9608 | 83.53 |
10:32 ET | 12534 | 83.5775 |
10:33 ET | 17698 | 83.435 |
10:35 ET | 11590 | 83.44 |
10:37 ET | 5263 | 83.395 |
10:39 ET | 30313 | 83.49 |
10:42 ET | 11649 | 83.575 |
10:44 ET | 12960 | 83.8 |
10:46 ET | 16110 | 83.685 |
10:48 ET | 17246 | 83.76 |
10:50 ET | 19815 | 83.84 |
10:51 ET | 12603 | 83.945 |
10:53 ET | 20910 | 84.085 |
10:55 ET | 22680 | 84.05 |
10:57 ET | 10800 | 83.95 |
11:00 ET | 11229 | 83.95 |
11:02 ET | 11388 | 83.825 |
11:04 ET | 9352 | 83.67 |
11:06 ET | 10831 | 83.56 |
11:08 ET | 7830 | 83.525 |
11:09 ET | 11624 | 83.62 |
11:11 ET | 8301 | 83.705 |
11:13 ET | 10836 | 83.7 |
11:15 ET | 10261 | 83.83 |
11:18 ET | 15209 | 83.6 |
11:20 ET | 6614 | 83.59 |
11:22 ET | 10417 | 83.49 |
11:24 ET | 8050 | 83.645 |
11:26 ET | 7434 | 83.62 |
11:27 ET | 11268 | 83.83 |
11:29 ET | 9080 | 83.87 |
11:31 ET | 13698 | 84.03 |
11:33 ET | 5932 | 84 |
11:36 ET | 19215 | 84.13 |
11:38 ET | 20706 | 84.36 |
11:40 ET | 16203 | 84.39 |
11:42 ET | 1771 | 84.39 |
11:44 ET | 16525 | 84.38 |
11:45 ET | 9995 | 84.39 |
11:47 ET | 12284 | 84.31 |
11:49 ET | 13299 | 84.42 |
11:51 ET | 12671 | 84.405 |
11:54 ET | 9002 | 84.29 |
11:56 ET | 8288 | 84.195 |
11:58 ET | 9694 | 84.205 |
12:00 ET | 15522 | 84.09 |
12:02 ET | 9284 | 84.04 |
12:03 ET | 7990 | 84.115 |
12:05 ET | 10208 | 84.01 |
12:07 ET | 3036 | 84.03 |
12:09 ET | 18197 | 84.005 |
12:12 ET | 11147 | 83.98 |
12:14 ET | 17698 | 83.92 |
12:16 ET | 5490 | 83.88 |
12:18 ET | 13457 | 84.06 |
12:20 ET | 11894 | 84.1 |
12:21 ET | 9191 | 84.11 |
12:23 ET | 10787 | 84.23 |
12:25 ET | 13308 | 84.22 |
12:27 ET | 9814 | 84.14 |
12:30 ET | 9753 | 84.24 |
12:32 ET | 3625 | 84.32 |
12:34 ET | 8033 | 84.275 |
12:36 ET | 9343 | 84.27 |
12:38 ET | 5744 | 84.38 |
12:39 ET | 13423 | 84.4397 |
12:41 ET | 12147 | 84.35 |
12:43 ET | 7128 | 84.44 |
12:45 ET | 10943 | 84.325 |
12:48 ET | 8299 | 84.41 |
12:50 ET | 12216 | 84.175 |
12:52 ET | 9381 | 84.195 |
12:54 ET | 6551 | 84.255 |
12:56 ET | 10716 | 84.205 |
12:57 ET | 6869 | 84.21 |
12:59 ET | 7858 | 84.28 |
01:01 ET | 5728 | 84.27 |
01:03 ET | 8231 | 84.35 |
01:06 ET | 10465 | 84.34 |
01:08 ET | 9625 | 84.31 |
01:10 ET | 7609 | 84.285 |
01:12 ET | 7719 | 84.22 |
01:14 ET | 7787 | 84.105 |
01:15 ET | 11865 | 84.145 |
01:17 ET | 9317 | 84.19 |
01:19 ET | 6903 | 84.39 |
01:21 ET | 8920 | 84.34 |
01:24 ET | 8117 | 84.335 |
01:26 ET | 13134 | 84.35 |
01:28 ET | 7431 | 84.355 |
01:30 ET | 8882 | 84.28 |
01:32 ET | 8909 | 84.165 |
01:33 ET | 5793 | 84.155 |
01:35 ET | 7429 | 84.12 |
01:37 ET | 12806 | 84.15 |
01:39 ET | 5938 | 84.185 |
01:42 ET | 9794 | 84.17 |
01:44 ET | 6810 | 84.3 |
01:46 ET | 10875 | 84.26 |
01:48 ET | 17281 | 84.38 |
01:50 ET | 11859 | 84.355 |
01:51 ET | 9370 | 84.275 |
01:53 ET | 8358 | 84.275 |
01:55 ET | 4839 | 84.25 |
01:57 ET | 9355 | 84.28 |
02:00 ET | 7744 | 84.265 |
02:02 ET | 13566 | 84.25 |
02:04 ET | 4332 | 84.215 |
02:06 ET | 8700 | 84.12 |
02:08 ET | 12898 | 84.03 |
02:09 ET | 5017 | 84.055 |
02:11 ET | 12169 | 84.035 |
02:13 ET | 18481 | 84.04 |
02:15 ET | 4081 | 84.065 |
02:18 ET | 14240 | 84.115 |
02:20 ET | 23099 | 84.01 |
02:22 ET | 13169 | 83.89 |
02:24 ET | 6032 | 83.83 |
02:26 ET | 17421 | 83.98 |
02:27 ET | 12420 | 84.06 |
02:29 ET | 15005 | 83.985 |
02:31 ET | 19850 | 83.695 |
02:33 ET | 9753 | 83.6 |
02:36 ET | 4927 | 83.67 |
02:38 ET | 15522 | 83.71 |
02:40 ET | 7387 | 83.705 |
02:42 ET | 8410 | 83.68 |
02:44 ET | 10436 | 83.695 |
02:45 ET | 6926 | 83.71 |
02:47 ET | 4215 | 83.735 |
02:49 ET | 6184 | 83.75 |
02:51 ET | 8185 | 83.715 |
02:54 ET | 8235 | 83.65 |
02:56 ET | 8506 | 83.63 |
02:58 ET | 12152 | 83.585 |
03:00 ET | 3253 | 83.64 |
03:02 ET | 14390 | 83.46 |
03:03 ET | 8674 | 83.38 |
03:05 ET | 10903 | 83.42 |
03:07 ET | 8403 | 83.44 |
03:09 ET | 9360 | 83.41 |
03:12 ET | 7014 | 83.52 |
03:14 ET | 10736 | 83.56 |
03:16 ET | 8033 | 83.735 |
03:18 ET | 10012 | 83.87 |
03:20 ET | 15664 | 83.98 |
03:21 ET | 14612 | 83.94 |
03:23 ET | 9859 | 83.92 |
03:25 ET | 15125 | 83.9 |
03:27 ET | 10975 | 83.671 |
03:30 ET | 11475 | 83.61 |
03:32 ET | 12643 | 83.84 |
03:34 ET | 11625 | 83.65 |
03:36 ET | 19553 | 83.455 |
03:38 ET | 19670 | 83.52 |
03:39 ET | 17263 | 83.49 |
03:41 ET | 23078 | 83.515 |
03:43 ET | 20045 | 83.54 |
03:45 ET | 22986 | 83.54 |
03:48 ET | 15874 | 83.56 |
03:50 ET | 25389 | 83.47 |
03:52 ET | 47137 | 83.25 |
03:54 ET | 51122 | 83.215 |
03:56 ET | 116301 | 83.05 |
03:57 ET | 107704 | 83.02 |
03:59 ET | 2006536 | 82.94 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomarin Pharmaceutical Inc | 15.4B | 78.5x | --- |
Beigene Ltd | 17.1B | -20.6x | --- |
United Therapeutics Corp | 12.3B | 13.0x | +8.22% |
Neurocrine Biosciences Inc | 13.4B | 37.0x | +62.04% |
Medpace Holdings Inc | 12.5B | 41.3x | +35.10% |
Alnylam Pharmaceuticals Inc | 18.9B | -56.6x | --- |
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.4B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 189.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.31 |
EPS | $1.06 |
Book Value | $26.25 |
P/E Ratio | 78.5x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | 49.4x |
Operating Margin | 7.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.